SFX by Ex Libris Inc.

Title:	Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing
Source:	Nature [0028-0836] Larder, B A yr:1993

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Souli, C. "Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists." The Journal of Antimicrobial Chemotherapy (2010): 749-751.
description	2.	KELLAM, P. "ZIDOVUDINE TREATMENT RESULTS IN THE SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WHOSE GENOTYPES CONFER INCREASING LEVELS OF DRUG-RESISTANCE." The Journal of general virology 75.2 (1994): 341-351.
description	3.	Coffin, John M M. "Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis." Journal of clinical microbiology 43.1 (2004): 406-13.
description	4.	Lemey, Oliver G G. "HIV evolutionary dynamics within and among hosts." AIDS reviews 8.3 (2006): 125-40.
description	5.	Boucher, C A B. "HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment." AIDS 6.11 (1992): 1259-.
description	6.	Arendrup, M. "Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies." Journal of acquired immune deficiency syndromes 5.3 (1992): 303-307.
description	7.	Coffin, J M M. "HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy." Science 267.5197 (1994): 483-9.
description	8.	Gregson, S. "Hiv decline associated with behavior change in eastern in eastern zimbabwe." Science 311.5761: 664-666.
description	9.	Marlink, M. "Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana." Journal of acquired immune deficiency syndromes 40.3 (2005): 336-43.
description	10.	Little, Douglas D J. "Antiretroviral-drug resistance among patients recently infected with HIV." New England Journal of Medicine, The 347.6 (2002): 385-94.
description	11.	KELLAM, P. "5TH MUTATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO THE DEVELOPMENT OF HIGH-LEVEL RESISTANCE TO ZIDOVUDINE." Proceedings of the National Academy of Sciences of the United States of America 89.5 (1992): 1934-1938.
description	12.	Lemey, A. "Reconstructing the initial global spread of a human influenza pandemic: a Bayesian spatial-temporal model for the global spread of H1N1pdm." PLoS Curr Influenza 1 (2009).
description	13.	Heeney, Jonathan L. "Origins of HIV and the Evolution of Resistance to AIDS." Science 313.5786 (2006): 462-6.
description	14.	Gregson, S. "Community group participation: can it help young women to avoid HIV? An exploratory study of social capital and school education in rural Zimbabwe." Social science & medicine 58.11 (2004): 2119-2132.
description	15.	Kuiken, C L L. "Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic." Proceedings of the National Academy of Sciences of the United States of America 90.19 (1993): 9061-5.
description	16.	Shao, Humphrey J. "Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania." AIDS research and human retroviruses 25.12 (2009): 1277-85.
description	17.	Wainberg, M A A. "Public health implications of antiretroviral therapy and HIV drug resistance." JAMA 279.24 (1998): 1977-83.
description	18.	Worobey, M. "Evolutionary aspects of recombination in RNA viruses." The Journal of general virology 80.10 (1999): 2535-43.
description	19.	Korber, B. "Evolutionary and immunological implications of contemporary HIV-1 variation." British Medical Bulletin 58.1 (2001): 19-42.
description	20.	Nara, P L L. "Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development." The FASEB journal 5.10 (1991): 2427-2436.